Creative Biolabs

Nucleic Acid/Oligonucleotide Conjugation Services

Creative Biolabs provides Nucleic Acid/Oligonucleotide Conjugation Services for researchers developing targeted delivery systems and diagnostic probes.

By combining sequence-defined oligonucleotides with functional payloads, conjugation can improve serum stability, circulation time, cellular uptake, and analytical signal output.

Project success often depends on selecting the right modification site, linker design, and analytical characterization strategy. We tailor each project based on molecule type and application goals.

Scientific visualization of oligonucleotide conjugation

Our Nucleic Acid and Oligonucleotide Conjugation Service

Structural & PK Modification

Optimizing Physiochemical Properties for Therapeutic Success

We specialize in sophisticated chemical modifications that overcome the inherent limitations of natural oligonucleotides. Our platform addresses core challenges such as rapid renal clearance and enzymatic degradation through site-specific PEGylation and lipid tailoring (e.g., cholesterol, DPC). By precisely controlling the density and position of these modifications, we achieve optimal pharmacokinetic profiles while maintaining target-binding potency.

  • Key advantages:Enhanced nuclease resistance, extended systemic half-life, and significantly improved aqueous solubility for lipophilic constructs.
  • Typical applications:Systemic delivery optimization for siRNA, ASOs, and mRNA, as well as fine-tuning biodistribution for antisense therapies.

Targeting & Functional Conjugation

Ligands for Precision Delivery

Precision delivery is the cornerstone of our functional conjugation strategies. We leverage high-affinity ligands—including cell-penetrating peptides (CPPs), tissue-specific aptamers, and small molecules like folic acid—to trigger receptor-mediated endocytosis. Our chemical expertise ensures that the conjugation process preserves both the ligand’s recognition capability and the oligonucleotide’s regulatory activity.

  • Key advantages:Superior cell-type specificity, reduced off-target toxicity, and enhanced intracellular bioavailability.
  • Typical applications:Development of next-generation AOCs (Antibody-Oligonucleotide Conjugates), tumor-targeted gene silencing, and precision immunomodulation.

Material, Carrier & Detection

Integrated Solutions for Diagnostics

Beyond in vivo therapeutic delivery, we provide robust solutions for immobilizing oligonucleotides onto diverse solid supports and carriers. Whether it’s functionalizing magnetic beads for high-efficiency sample capture or conjugating quantum dots and fluorescent dyes for ultra-sensitive bioimaging, we optimize the interface chemistry to minimize non-specific binding and maximize the signal-to-noise ratio.

  • Key advantages:High surface loading density, excellent colloidal stability, and versatile detection options (fluorescence, chemiluminescence).
  • Typical applications:IVD assay development, spatial biology probes, nanoparticle-based delivery vehicles, and advanced molecular sensing.

Technology Platform for Oligonucleotide Conjugation

Creative Biolabs has established an end-to-end oligonucleotide conjugation platform covering synthesis, reaction development, purification, and analytical characterization.

Synthesis & Pretreatment Platform
Our automated oligonucleotide synthesizers support the preparation of high-purity oligonucleotides with customized lengths and terminal modifications. Vacuum concentrators are used for sample concentration and drying after purification, while automated buffer exchange systems support desalting and reaction condition matching before conjugation.
Reaction & Purification Platform
Temperature-controlled shaking reactors help maintain precise reaction conditions and kinetics. Preparative and semi-preparative HPLC systems are used for removing excess ligands and separating conjugate species with different loading levels. Advanced automated chromatography systems support SEC and affinity purification for complex conjugate systems.
Analytical & Characterization Platform
LC-MS is used for molecular weight confirmation, conjugation verification, and sequence integrity analysis. CE supports purity and charge heterogeneity analysis. UV-Vis can be used to estimate conjugation efficiency, while DLS monitors aggregation behavior and colloidal stability.

Oligonucleotide Conjugation Workflow

Our standard oligonucleotide conjugation workflow includes five key steps:

Applications of Nucleic Acid and Oligonucleotide Conjugation

Our nucleic acid/oligonucleotide conjugation services can be used in a wide range of research scenarios:

  • Delivery optimization and in vivo stability enhancement of siRNA, ASOs, aptamers, and other oligonucleotide therapeutics
  • Tumor-targeted, liver-targeted, or receptor-mediated delivery studies
  • Construction of AOCs, ODCs, and multifunctional oligonucleotide therapeutics
  • Development of IVD probes, capture probes, fluorescent probes, and barcode probes
  • Bioimaging, pharmacokinetic tracking, and cellular uptake studies
  • Functionalization of beads, nanoparticles, and surface-based carriers
  • High-throughput screening, spatial biology, molecular sensing, and functional material development

Fig.1 The delivery technologies for oligonucleotides (ONs).1

Why Choose Creative Biolabs?

  • One-Stop Development CapabilityFrom oligonucleotide modification and conjugation strategy design to purification and characterization, we provide an integrated workflow that helps reduce time loss and quality risk across multiple vendors.
  • Flexible Chemistry OptionsWe support multiple proven oligonucleotide conjugation chemistries, including click chemistry, thiol-selective conjugation, amide coupling, and enzymatic ligation, with routes tailored to different molecular formats and project goals.
  • Broad Molecular CompatibilityOur platform supports siRNA, ASOs, DNA, RNA, aptamers, peptides, small molecules, polymers, nanoparticles, and particulate carriers across a broad range of project types.
  • Orthogonal Analytical VerificationWe apply LC-MS, HPLC, CE, UV-Vis, DLS, or related techniques to ensure each conjugate is verifiable, traceable, and suitable for downstream use.
  • Application-Oriented CustomizationWe focus not only on successful conjugation, but also on whether the final construct truly improves delivery, targeting, detection, or imaging performance in line with the client’s research objective.

What Our Clients Say

“Creative Biolabs helped us rapidly optimize a peptide-siRNA conjugation route with solid purity and reproducibility. Their analytical feedback was especially valuable during our early screening stage.”

— Dr. Wilson Biotechnology Company in Boston

“We were looking for a partner capable of handling both oligonucleotide modification and nanoparticle conjugation. The team delivered a well-characterized construct package that supported our downstream validation smoothly.”

— Prof. Chen Research Institute in Singapore

“Their scientists provided practical guidance on linker selection and purification strategy for a folate-oligonucleotide project. The communication was efficient and technically grounded.”

— Dr. Martinez Oncology R&D Team, California

Frequently Asked Questions

Reference

Hammond, Suzan M., et al. "Delivery of oligonucleotide‐based therapeutics: challenges and opportunities." EMBO molecular medicine 13.4 (2021): e13243. Distributed under Open Access license CC BY 4.0.

i

For research use only. Not intended for any clinical use.

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.